NCT06200909 Self-Care Training for Family Caregivers of Persons With Neurodegeneration
| NCT ID | NCT06200909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Toronto Metropolitan University |
| Condition | Caregiver Burden |
| Study Type | INTERVENTIONAL |
| Enrollment | 232 participants |
| Start Date | 2024-06 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 232 participants in total. It began in 2024-06 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess whether an 8-week mindfulness program enhances psychological well-being (e.g., stress, depressive symptoms), biological indicators of stress (e.g., inflammation), and cognitive function (e.g., attentional ability) in primary family caregivers of persons with dementia or a related neurodegenerative disease. A total of 232 primary family caregivers aged 50+ years of age will be recruited for this study and randomized to one of three groups: mindfulness meditation (MM), psychoeducation (PSY) or caregiver respite (CR). All participants will complete three testing sessions: baseline (pre-intervention \[T1\]), post 8-week follow-up (post-intervention, \[T2\]), and 12-month follow-up (T3).
Eligibility Criteria
Inclusion Criteria: * 50+ years of age * Currently a primary family caregiver * Fluent in English Exclusion Criteria: * Existing mindfulness practice * Diagnosed/Presenting with Post-traumatic Stress Disorder; Substance Disorder; Psychosis * Unable to attend 8 sessions * No access to a computer or high-speed internet * Not willing to be randomized
Contact & Investigator
Alexandra Fiocco, PhD
PRINCIPAL INVESTIGATOR
Toronto Metropolitan University
Frequently Asked Questions
Who can join the NCT06200909 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 100 Years, studying Caregiver Burden. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06200909 currently recruiting?
Yes, NCT06200909 is actively recruiting participants. Contact the research team at star.lab@torontomu.ca for enrollment information.
Where is the NCT06200909 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06200909 clinical trial?
NCT06200909 is sponsored by Toronto Metropolitan University. The principal investigator is Alexandra Fiocco, PhD at Toronto Metropolitan University. The trial plans to enroll 232 participants.